XML 148 R133.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segments of Business - Schedule Of Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Revenues                      
Total Revenues $ 48,713 $ 50,130 $ 49,957 $ 49,733 $ 46,678 $ 47,899 $ 48,761 $ 47,546 $ 198,533 $ 190,884 $ 179,045
Operating profit                      
Operating income                 7,109 3,545 2,968
Interest Expense                 (308) (353) (374)
Income from Continuing Operations Before Income Taxes                 6,891 3,250 2,657
Depreciation and amortization                      
Total                 910 885 1,017
Expenditures for long-lived assets                      
Total                 404 488 376
United States                      
Revenues                      
Total Revenues                 164,428 158,255 142,810
Foreign                      
Revenues                      
Total Revenues                 34,105 32,629 36,235
Operating Segments                      
Revenues                      
Total Revenues                 198,533 190,884 179,045
Operating profit                      
Operating income                 7,576 4,072 3,485
Operating Segments | Distribution Solutions                      
Revenues                      
Total Revenues                 195,923 187,999 175,976
Operating profit                      
Operating income                 3,361 3,553 3,047
Depreciation and amortization                      
Total                 735 669 750
Expenditures for long-lived assets                      
Total                 276 306 301
Operating Segments | Distribution Solutions | Reportable Subsegments | North America pharmaceutical distribution and services                      
Revenues                      
Total Revenues                 164,832 158,469 143,711
Operating Segments | Distribution Solutions | Reportable Subsegments | International pharmaceutical distribution and services                      
Revenues                      
Total Revenues                 24,847 23,497 26,358
Operating Segments | Distribution Solutions | Reportable Subsegments | Medical-Surgical distribution and services                      
Revenues                      
Total Revenues                 6,244 6,033 5,907
Operating Segments | Technology Solutions                      
Revenues                      
Total Revenues                 2,610 2,885 3,069
Operating profit                      
Operating income                 4,215 519 438
Depreciation and amortization                      
Total                 65 107 156
Expenditures for long-lived assets                      
Total                 30 15 27
Segment Reconciling Items                      
Operating profit                      
Corporate Expenses, Net                 (377) (469) (454)
Corporate                      
Depreciation and amortization                      
Total                 110 109 111
Expenditures for long-lived assets                      
Total                 $ 98 $ 167 $ 48